Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;100(3):189-201.
doi: 10.1002/bdra.23220. Epub 2014 Feb 27.

Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia

Affiliations
Review

Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia

Vineet Bhandari. Birth Defects Res A Clin Mol Teratol. 2014 Mar.

Abstract

Exposure to hyperoxia, invasive mechanical ventilation, and systemic/local sepsis are important antecedents of postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia (BPD). This review will summarize information obtained from animal (baboon, lamb/sheep, rat and mouse) models that pertain to the specific inflammatory agents and signaling molecules that predispose a premature infant to BPD.

Keywords: hyperoxia; infection; invasive ventilation; lung; newborn.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia (BPD)
The 3 major postnatal factors act on the immature lung initiating an inflammatory cascade involving specific cells and cytokines. Local/systemic sepsis is most prominent among the 3 to cause inflammation, followed by hyperoxia and invasive ventilation (as noted by the thickness of the arrows). These, in turn, instigate effects promoting cell death, cell cycle arrest, and abnormal production of growth factors, matrix proteins and vascular factors. Mediators that have been consistently reported to have the above noted effects have been listed in the figure. The net result is impaired alveolarization and dysregulated vascularization culminating in the pulmonary phenotype of BPD. Ang-2: Angiopoietin 2. For additional abbreviations and details, please see text.

References

    1. Aghai ZH, Faqiri S, Saslow JG, et al. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone. J Perinatol. 2008;28:149–155. - PubMed
    1. Aghai ZH, Saslow JG, Mody K, et al. IFN-gamma and IP-10 in tracheal aspirates from premature infants: Relationship with bronchopulmonary dysplasia. Pediatr Pulmonol. 2012 - PubMed
    1. Akram Khan M, Kuzma-O'Reilly B, Brodsky NL, et al. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol. 2006;26:428–435. - PubMed
    1. Alapati D, Rong M, Chen S, et al. Connective tissue growth factor antibody therapy attenuates hyperoxia-induced lung injury in neonatal rats. Am J Respir Cell Mol Biol. 2011;45:1169–1177. - PubMed
    1. Alapati D, Rong M, Chen S, et al. Inhibition of LRP5/6-mediated Wnt/beta-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats. Pediatr Res. 2013;73:719–725. - PubMed

Publication types

MeSH terms